{"id":39256,"date":"2026-04-21T11:39:22","date_gmt":"2026-04-21T11:39:22","guid":{"rendered":"https:\/\/g-medtech.com\/news\/?p=39256"},"modified":"2026-04-21T11:45:52","modified_gmt":"2026-04-21T11:45:52","slug":"inbrain-neuroelectronics-completes-first-in-human-study-enrollment-for-graphene-neural-interface","status":"publish","type":"post","link":"https:\/\/g-medtech.com\/news\/pl\/inbrain-neuroelectronics-completes-first-in-human-study-enrollment-for-graphene-neural-interface\/","title":{"rendered":"INBRAIN Neuroelectronics Completes First-in-Human Study Enrollment for Graphene Neural Interface"},"content":{"rendered":"<p class=\"wp-block-paragraph translation-block\">Barcelona-based&nbsp;<a href=\"https:\/\/g-medtech.com\/database\/medtech-players\/index\/inbrain-neuroelectronics\/\" target=\"_blank\" rel=\"noreferrer noopener\">INBRAIN Neuroelectronics<\/a> has completed patient recruitment in its first-in-human study evaluating a graphene-based cortical interface for brain decoding and mapping. A total of ten patients were enrolled, with eight treated surgically, and complete datasets were obtained from all eight. No perioperative device failure was observed during use. The study, sponsored by the University of Manchester and conducted with Northern Care Alliance NHS Foundation Trust, evaluated the graphene-based cortical interface during neurosurgical procedures for brain tumor resection.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The study demonstrated a favorable perioperative safety profile with no device-related adverse events observed in all eight patients treated up to surgical discharge. The primary endpoint includes a post-operative safety monitoring period of ninety days. In select cases involving awake surgery, patients performed functional tasks such as object naming, enabling researchers to evaluate the system&#8217;s performance in decoding speech representation in the brain at high resolution. Conventional electrodes are limited by rigidity, size, and signal sensitivity, whereas INBRAIN&#8217;s ultra-thin, highly flexible graphene-based electrodes are designed to conform to the brain&#8217;s surface and access hard-to-reach areas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">&#8220;The completion of patient enrollment in this first-in-human study marks an important step for INBRAIN and the field of neurotechnology,&#8221; said Carolina Aguilar, CEO and Co-founder of INBRAIN Neuroelectronics. &#8220;Graphene has the potential to fundamentally change how we interface with the brain, enabling higher resolution of neural function specific biomarkers, safer, and more intelligent brain-computer interface (BCI) systems.&#8221; Dr. David Coope, Chief Clinical Investigator and Consultant Neurosurgeon at the Manchester Centre for Clinical Neurosciences, noted that the ability to detect high-frequency neural activity with micrometer-scale precision provides a fundamentally new level of insight into brain-tumor interactions and functional brain decoding. Dr. Kostas Kostarelos, Co-Founder of INBRAIN and Chief Scientific Investigator of the study, added that the study demonstrates graphene can safely interface with the human brain and capture neural signals with exceptional fidelity to enable precise decoding of brain and speech-related patterns. Full results are expected to be announced later this year as the company advances toward commercialization.<\/p>","protected":false},"excerpt":{"rendered":"<p>The study enrolled ten patients with eight surgically treated, demonstrating a favorable perioperative safety profile with no device-related adverse events and no device failures, supporting graphene-based brain-computer interface (BCI) therapeutics for brain decoding and mapping.<\/p>","protected":false},"author":2,"featured_media":35383,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"colormag_page_layout":"default_layout","footnotes":""},"categories":[488,681,6,25],"tags":[802],"class_list":["post-39256","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","category-care-therapy","category-europe","category-products-technologies","tag-bci"],"_links":{"self":[{"href":"https:\/\/g-medtech.com\/news\/pl\/wp-json\/wp\/v2\/posts\/39256","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/g-medtech.com\/news\/pl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/g-medtech.com\/news\/pl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/pl\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/pl\/wp-json\/wp\/v2\/comments?post=39256"}],"version-history":[{"count":3,"href":"https:\/\/g-medtech.com\/news\/pl\/wp-json\/wp\/v2\/posts\/39256\/revisions"}],"predecessor-version":[{"id":39259,"href":"https:\/\/g-medtech.com\/news\/pl\/wp-json\/wp\/v2\/posts\/39256\/revisions\/39259"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/pl\/wp-json\/wp\/v2\/media\/35383"}],"wp:attachment":[{"href":"https:\/\/g-medtech.com\/news\/pl\/wp-json\/wp\/v2\/media?parent=39256"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/pl\/wp-json\/wp\/v2\/categories?post=39256"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/pl\/wp-json\/wp\/v2\/tags?post=39256"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}